Medical University Of Lodz — Sponsor Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

8 Recruiting

1 Completed trials

1 Countries active

34 Unique IMPs

100% Results reported

Phase III

Phase II/III

Phase II

Phase III: 5 Phase II/III: 1 Phase II: 3

Oversight events:

2 urgent safety measures 1 unexpected event across 2 trials

View oversight register →

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Acute myeloid leukaemia 1 Type 1 diabetes mellitus 1 Nephrotic syndrome 1 Fabry´s disease 1

Top IMPs

CLADRIBINE 1 GEMTUZUMAB OZOGAMICIN 1 LISDEXAMFETAMINE DIMESYLATE 1 METHYLPHENIDATE HYDROCHLORIDE 1 VENETOCLAX 1

All trials

9 total

Low dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease Recruiting

2025-521408-24-00 Phase III 1 country
Comparison of inclisiran or alirocumab to standard therapy in pediatric heterozygous familial hypercholesterolemia (HeFH) – the head-to-head… Recruiting

2024-514523-42-00 Phase III 1 country
BOOSTER – Multicenter, Open Label, Randomized Control Phase III Trial Comparing the Efficacy and Safety of Two Rituximab Regimens in Mainten… Recruiting

2023-509755-13-00 Phase III 1 country
Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head-to-head COMBO-U… Recruiting

2023-506452-25-00 Phase II 1 country
LAMAinDiab - comparison of 2 pharmacological therapies (lisdexamphetamine vs methylphenidate) for pediatric patients with ADHD and type 1 di… Recruiting

2023-506862-30-00 Phase II 1 country LISDEXAMFETAMINE DIMESYLATE; METHYLPHENIDATE HYDROCHLORIDE
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting

2024-518316-39-00 Phase II/III 1 country
Randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of dimethyl fumarate in brain atrophy reduction, synaptic … Recruiting

2024-517214-16-00 Phase II 1 country
MAGIC AML - Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy - of Acute Myeloid Leu… Recruiting

2023-503394-37-00 Phase III 1 country CLADRIBINE; GEMTUZUMAB OZOGAMICIN; VENETOCLAX
A clinical trial evaluating the efficacy and safety of the drugs - cyclosporine and methotrexate in children and adolescents with moderate t… Ended

2023-509759-15-00 Phase III 1 country

Showing 1–9 of 9 trials

← All sponsors A–Z